O TYM ODCINKU
Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical operations experts into the decision-making process can help proactively address some of the biggest challenges facing trials today.
In this podcast, Raul Lima, MBA, EVP, Strategic Clinical Operations of inSeption Group, explains the difference between clinical development and clinical operations, misconceptions CMOs have about clinical operations and how to successfully navigate the complexities of clinical trial execution.
For more information about inSeption Group, visit inSeptionGroup.com.
For more information about the annual Chief Medical Officer Summit 360° and its affiliated editorials, podcasts and webcasts, please visit CMO360.org.
In this podcast, Raul Lima, MBA, EVP, Strategic Clinical Operations of inSeption Group, explains the difference between clinical development and clinical operations, misconceptions CMOs have about clinical operations and how to successfully navigate the complexities of clinical trial execution.
For more information about inSeption Group, visit inSeptionGroup.com.
For more information about the annual Chief Medical Officer Summit 360° and its affiliated editorials, podcasts and webcasts, please visit CMO360.org.
Język angielski
Stany Zjednoczone
W TYM ODCINKU
TRANSKRYPCJA 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki PharmaTalkRadio.
INNE ODCINKI W TYM PODCASCIE
For more information, go to theconferenceforum.org
For more information, visit theconferenceforum.org
For more information, visit theconferenceforum.org
For more information, visit theconferenceforum.org
As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed.
In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug deve…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Pharma Talk Radio, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
